SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-040015
Filing Date
2012-07-18
Accepted
2012-07-18 16:51:07
Documents
3
Period of Report
2012-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v318898_8k.htm 8-K 31285
2 EXHIBIT 3.1 v318898_ex3-1.htm EX-3.1 113441
3 EXHIBIT 4.1 v318898_ex4-1.htm EX-4.1 49902
  Complete submission text file 0001144204-12-040015.txt   196181
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 12968331
SIC: 2836 Biological Products, (No Diagnostic Substances)